| __timestamp | Amneal Pharmaceuticals, Inc. | CymaBay Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 8185000 |
| Thursday, January 1, 2015 | 109679000 | 8871000 |
| Friday, January 1, 2016 | 118757000 | 9645000 |
| Sunday, January 1, 2017 | 109046000 | 12387000 |
| Monday, January 1, 2018 | 230435000 | 14381000 |
| Tuesday, January 1, 2019 | 289598000 | 19238000 |
| Wednesday, January 1, 2020 | 326727000 | 17425000 |
| Friday, January 1, 2021 | 365504000 | 23040000 |
| Saturday, January 1, 2022 | 399700000 | 25116000 |
| Sunday, January 1, 2023 | 429675000 | 51953000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Amneal Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc. from 2014 to 2023. Over this period, Amneal Pharmaceuticals has consistently outpaced CymaBay in SG&A spending, with a staggering 408% increase from 2014 to 2023. In contrast, CymaBay's SG&A expenses grew by 535% during the same period, albeit from a much smaller base. By 2023, Amneal's SG&A expenses reached approximately $429 million, while CymaBay's were around $52 million. This disparity highlights the scale and operational differences between the two companies. As the pharmaceutical landscape continues to shift, monitoring these financial metrics provides valuable insights into each company's strategic priorities and market positioning.
Selling, General, and Administrative Costs: Novo Nordisk A/S vs CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Catalent, Inc. and CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and Merus N.V.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
Amneal Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: CymaBay Therapeutics, Inc. vs Wave Life Sciences Ltd.
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Novavax, Inc. Trends and Insights